News | News By Subject | News by Disease News By Date | Search News

Alopecia (Baldness) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web

Press Releases
Kerastem Completes Enrollment in US Phase II Hair Growth Clinical Trial     9/23/2016
Mallinckrodt (MNK) Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products     9/1/2016
Mylan (MYL) Launches Generic Propecia Tablets     8/1/2016
Incyte (INCY) Reports 2016 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs     5/9/2016
Concert Pharmaceuticals, Inc. (CNCE) Unveils CTP-543 For Treatment Of Alopecia Areata     5/5/2016
Kerastem Hair Growth Clinical Trial Update     4/22/2016
Samumed Presents At The Annual Meeting Of The American Academy of Dermatology Safety And Efficacy Results From Its Phase 2 Androgenetic Alopecia (AGA) Trial     3/7/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Actikerall     2/22/2016
Kerastem's Phase II STYLE Clinical Trial Actively Enrolling Female & Male Subjects with Early Stage Hair Loss     1/21/2016
Samumed Announces Increases In Both Hair Count And Hair Density Observed In Its Phase II Study For A Potential Treatment Of Androgenetic Alopecia (AGA)     12/4/2015
Samumed Completes Phase II Study For Its Potential Treatment Of Androgenetic Alopecia: Safety Data Show No Serious Adverse Events In Any Treated Patient     11/23/2015
Perrigo Company (PRGO) Confirms Filing for Generic Version of Men's Rogaine(R) Foam     10/13/2009
Merck & Co., Inc. (MRK) Prostate Drug Cleared of Causing Aggressive Tumors     9/12/2007
Auriga Laboratories, Inc. (ARGA.OB) Acquires Exclusive U.S. Rights to New Hair Loss Product     6/7/2007
New Web Site From Merck & Co., Inc. (MRK) Offers Men Hope With Information On Male Pattern Hair Loss     9/29/2006